Short answer: cannabis may take the edge off arthritis pain for some people, but it does not treat the disease. It will not rebuild cartilage, slow joint damage, or quiet the immune attack behind rheumatoid arthritis. The best human evidence comes from a prescription THC-CBD spray studied in rheumatoid arthritis. Most of what you see on shelves, including CBD creams and gummies, sits on much thinner ground.

What the research shows

The most cited human trial used nabiximols, a mouth spray with roughly equal parts THC and CBD. In a randomized, placebo-controlled study of rheumatoid arthritis patients published in 2006, the spray improved pain on movement and sleep quality over five weeks. That is a real signal, but it is one study with a modest number of participants, and it tested a regulated pharmaceutical product, not a jar of gummies.

For osteoarthritis, the picture gets blurrier. A few small trials and case reports suggest topical or oral cannabinoids might reduce knee pain, but sample sizes are tiny, follow-up is short, and study designs vary enough that comparing them is hard. The 2017 National Academies report on cannabis and health found substantial evidence for chronic pain in adults, yet it did not identify arthritis as an area with enough evidence to draw a firm conclusion.

Preclinical work is where most of the enthusiasm comes from. Cannabinoid receptors sit on immune cells and nerve endings in joints, and animal models of arthritis show reduced swelling and pain signaling. Mice are not people, and plenty of drugs that work in mice fail in humans.

Cannabis is not a disease-modifying drug

This is the part worth repeating. Arthritis has two problems: pain, and ongoing damage to the joint. Cannabinoids may address the first. Nothing in the current evidence suggests they touch the second. If you have rheumatoid arthritis, psoriatic arthritis, or another inflammatory form, the drugs that protect your joints are DMARDs such as methotrexate, biologics, and JAK inhibitors. Dropping those for cannabis would be a serious mistake.

The American College of Rheumatology's osteoarthritis guideline lists exercise, weight management, topical NSAIDs, and steroid injections. Cannabis is not on it.

THC, CBD, and full-spectrum products

THC and CBD behave differently, and the difference matters for arthritis.

• THC binds directly to CB1 receptors in the brain and nervous system. That is where the pain-relieving and psychoactive effects come from. It also brings impairment, drowsiness, and in some people, anxiety.
• CBD binds CB1 and CB2 weakly. Its effects seem to run through other pathways, including serotonin receptors and anti-inflammatory signaling. It will not get you high.
• Full-spectrum extracts keep trace THC and other plant compounds. Some users report better relief than isolated CBD, but that idea rests more on anecdote than trial data.

How people use it

Topicals dominate the arthritis conversation because they target the joint with minimal psychoactivity. The tradeoff is that skin absorption is inconsistent, and little research confirms how much CBD a cream actually delivers to the joint capsule. Sublingual tinctures and edibles last longer but take 30 to 90 minutes to kick in. Inhaled forms work in minutes and wear off fast. Start low, go slow, and change one variable at a time so you know what helped.

Risks and drug interactions

CBD inhibits the CYP450 enzyme family, the same system your liver uses to clear many medications. That list includes blood thinners like warfarin, some seizure drugs, certain antidepressants, and a range of other prescriptions. High-dose CBD has been linked to liver enzyme elevations. Common side effects include drowsiness, dry mouth, diarrhea, and appetite changes. THC adds impairment, which rules out driving. If you take any prescription drug, run it past your pharmacist first.

Buying legally and safely

Hemp-derived CBD with no more than 0.3% THC is federally legal under the 2018 Farm Bill. Medical cannabis with higher THC is legal in many states but remains illegal at the federal level. That split means quality varies.

I look for a batch-specific certificate of analysis from an ISO-accredited lab. It should show cannabinoid potency, and it should screen for pesticides, heavy metals, residual solvents, and microbials. A COA that only lists CBD content tells you nothing about what else is in the bottle. Match the batch number on the COA to the number on your product.

What to ask your rheumatologist

Bring it up as a pain management question, not a treatment question. Ask whether cannabis could interact with your current drugs, whether it is safe with your specific diagnosis, and whether a topical might be worth trying alongside your existing plan. Some rheumatologists are open to the conversation. Others are not, but they still need to know what you are taking.